Sentence examples for biomedical governance from inspiring English sources

They close by suggesting this evidences a wider trend in the complexity and uncertainty of biomedical governance that requires closer attention by all.

We are in the presence of an intense process of control and regulation of bodies "from inside out" as a type of biomedical governance (p.181) [ 9].

Many of these substantive forces that constitute the co-producing, multiple dimensions of science, society and the market in the biomedical governance field have been identified, by way of illustration, in the foregoing sections of this discussion.

To summarise and bring together the threads of our concept-mapping project, we return to our 'triangle of tensions' as a heuristic to describe the main broad dimensions of biomedical governance.

We will link up our discussion of general trends, tensions and approaches taken to academic discussions on changes in biomedical research governance more broadly.

We believe that the methodology and the graphic representations of data will provide valuable and easy-to-grasp information that can assist professionals and the general public in understanding and improving biomedical research governance.

In this piece, then, I try to illustrate how the 'political' in biobank infrastructure's development is related to different meanings of 'politics' or 'the political' within biomedical informatics and its governance.

Public involvement activities (PIAs) are promoted and conducted as a cornerstone of good governance in biomedical research and innovation (BMRI).

This paper will use BGI as a point of departure to reflect on some crucial bioethical issues in the existing system of governance of biomedical research in China.

At the same time we can expect that their strategies on the emerging governance of biomedical innovation through such mechanisms as TRIPS and international ethical guidelines will become considerably more proactive.

And the need to identify points and arenas of potential intervention, negotiation and conflict between the Rising Powers and other states in the different levels and nodes of the transnational governance of biomedical innovation, both public and private.